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Abstract
ABCB6, a member of the adenosine triphosphate–binding cassette (ABC) transporter family, has been proposed to be
responsible for the mitochondrial uptake of porphyrins. Here we show that ABCB6 is a glycoprotein present in the
membrane of mature erythrocytes and in exosomes released from reticulocytes during the final steps of erythroid
maturation. Consistent with its presence in exosomes, endogenous ABCB6 is localized to the endo/lysosomal compartment,
and is absent from the mitochondria of cells. Knock-down studies demonstrate that ABCB6 function is not required for de
novo heme biosynthesis in differentiating K562 cells, excluding this ABC transporter as a key regulator of porphyrin
synthesis. We confirm the mitochondrial localization of ABCB7, ABCB8 and ABCB10, suggesting that only three ABC
transporters should be classified as mitochondrial proteins. Taken together, our results challenge the current paradigm
linking the expression and function of ABCB6 to mitochondria.
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Introduction
ATP-binding cassette (ABC) transporters comprise a superfam-
ily of membrane spanning multidomain proteins. ABC proteins
are located in the membrane compartment of the cells, where they
mediate translocation of various molecules across these barriers.
The functional significance of ABC transporters is suggested by the
evolutionary conservation of this protein superfamily. Based on
sequence homology, 48 different ABC proteins (grouped into
seven subfamilies ranging from A to G) have been defined in the
human genome. Most human ABC proteins function as efflux
pumps, translocating their substrates into the extracellular space or
intracellular organelles. Human ABC transporters may be
expressed in the plasma membranes of the cells, and also in
intracellular membrane compartments including the endoplasmic
reticulum (ER), lysosomes, peroxisomes and mitochondria.
ABCB6 belongs to the B (MDR/TAP) sub-family of ATP-binding
cassette transporters. The B subfamily consists of 11 members,
with functions ranging from the translocation of phosphatidylcho-
line (ABCB4-MDR3) to secretion of bile acids (ABCB11) or the
protection of cells against xenobiotics (ABCB1-MDR1/Pgp). The
ABCB subfamily contains seven half transporters, of which four
(ABCB6, ABCB7, ABCB8 and ABCB10) are believed to reside in
the mitochondria. ABCB2 and ABCB3 (TAP1-2) act as hetero-
dimers mediating the translocation of immunogenic peptides from
the cytosol into the endoplasmic reticulum, ABCB9 has been
localized to the lysosomes [1–2], and the cellular localization of
ABCB5 remains to be clarified.
The exact physiological function of mitochondrial ABC trans-
portersisnotknown.Presumably,theyplayaroleinthetransportof
solutes across mitochondrial membranes (thus regulating the
intramitochondrial milieu), or in the communication of signals
transmitted from the mitochondria to the cell. The inner mitochon-
drial membrane ABC transporters most likely act as exporters:
mutations of ABCB7 result in mitochondrial iron overload [3]
(although the exact nature of the transported substrate remains
elusive),andABCB8isalsobelievedtobeinvolvedinmitochondrial
ironexport[4].ThehighexpressionofABCB10intissuesrelated to
hematopoiesis suggests a role in erythroid differentiation, with a
function presumably contributing to the tight regulation of
mitochondrial iron acquisition and heme synthesis [5].
The first report describing ABCB6 function was based on the
investigation of a Saccharomyces cerevisiae mutant strain lacking the
mitochondrial ABC transporter Atm1p [6]. Atm1p knockout cells
accumulate highmitochondrial iron levels and are moresensitive to
oxidative stress [7,8], iron-starvation [9] and heavy metal toxicity
[10]. Based on the analysis of this complex phenotype, Atm1p is
believed to transport a yet unknownsubstrate that has an important
roleinthebiogenesisofcytosolic/nucleariron-sulfurproteinsaswell
as in regulating the overall mitochondrial iron homeostasis
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4[11,12,13]. In complementation studies using yeast strains lacking
Atm1p, the human ABCB6 protein (formerly known as MTABC3)
wasshowntoproviderescuefromthesephenotypicalterations.Based
on this result, ABCB6 was suggested to be the human ortholog of
Atm1p [6]. In 2006, Krishnamurthy and colleagues reported that
ABCB6 catalyzes the mitochondrial uptake of coproporphyrin III
(CPIII), an oxidized derivative of the heme synthesis intermediate,
coproporphyrinogenIII(CPgenIII),therebyservingasanimportant
regulator of cellular porphyrinbiosynthesis [14].
For several reasons, we consider both suggestions controversial.
First, ABCB6 was assigned to the outer mitochondrial membrane
with its nucleotide binding domains facing the cytoplasm.
According the currently accepted model, this orientation implies
an inward transport (i.e. mitochondrial import), which is difficult
to reconcile with the export function of Atm1p that resides in the
inner mitochondrial membrane. Second, the outer mitochondrial
membrane is permeable to small molecules, in contrast to the
inner membrane that represents an impermeable membrane
barrier. Third, ABCB6 was shown to undergo glycosylation [15]
and ER/Golgi transition [16]. In addition to its mitochondrial
localization, ABCB6 was also detected in the plasma membrane
[17], the Golgi apparatus [16], and in organelles of the vesicular
system [18,19,20,21].
While each ABC transporter may have a dedicated physiolog-
ical function, their overall role seems to be tied to the
‘‘chemoimmunity’’ network providing resistance against xenobi-
otic stress (for more details see [22–23]). Thus, with the exception
of a few notable examples (such as CFTR or SUR1/2), the
pathophysiological conditions associated with ABC proteins are
linked to the (lack of) transport of potentially toxic molecules.
Accordingly, several ABC transporters act as ‘‘multidrug resis-
tance’’ (MDR) proteins that provide resistance against chemo-
therapy in cancer [24]. Several reports suggest that the function of
ABCB6 may be related to MDR pumps. Expression of ABCB6
correlates with increased resistance to drugs in the NCI60 cell
panel [25] and various cell lines selected for resistance to arsenite,
cisplatin, camptothecin were found to possess elevated levels of
ABCB6 mRNA and protein [26]. Recently, overexpression of
ABCB6 has been linked to clinical resistance in acute myeloid
leukemia and to incomplete response to treatment in breast cancer
[27–28]. However, as classical MDR pumps (including ABCB1/
Pgp or ABCG2) function in the cell membrane to keep cytotoxic
drugs below a cell-killing threshold, the MDR function of ABCB6
is also difficult to reconcile with its suggested mitochondrial
localization and orientation.
To elucidate the role of ABCB6 in cellular physiology, it seems
important to analyze and establish the exact subcellular localiza-
tion of the native ABCB6 protein. Here we provide experimental
evidence based on independent methods proving that the
endogenous human ABCB6 is in fact an endolysosomal protein,
which is also expressed in red blood cells. We confirm the
mitochondrial localization of ABCB7, ABCB8 and ABCB10,
suggesting that only these three ABC transporters should be
classified as mitochondrial proteins. Taken together, our results
challenge the current paradigm linking the expression and
function of ABCB6 to mitochondria.
Results
ABCB6 is Expressed in the Endosomal/lysosomal
Compartment and is Absent from Mitochondria
K562, a Bcr-Abl+ erythroleukemia cell line is a widely used
human model system for studying the molecular mechanisms
implicated in hemoglobin production [29]. Based on experiments
conducted with K562 cells, ABCB6 was suggested to mediate
mitochondrial uptake of porphyrins [14]. In an effort to follow up
on these studies, we used differential centrifugation and immu-
noaffinity purification to analyze membrane fractions of parental
K562 cells; the endogenous ABCB6 protein was visualized using a
highly specific monoclonal antibody [17] in the context of
organelle markers. Although the mitochondria-containing fraction
obtained by differential centrifugation was positive for ABCB6-
labeling, mitochondrial localization of ABCB6 could not be
ascertained due to the persistent contamination of the mitochon-
drial fraction with lysosomes (Figure 1A). To overcome difficulties
associated with the overlapping physicochemical properties of
organelles, we used an alternative approach that relies on
superparamagnetic microbeads conjugated to anti-TOM22 anti-
body [30]. Membrane fractions isolated from K562 cell extracts by
immunomagnetic separation were positive for porin but negative
for LAMP-1, indicating mitochondria devoid of lysosomal
contamination (Figure 1B). In that setting, the ABCB6 signal
separated from the porin-positive fraction, and coincided with
LAMP-1.
Immunocytochemical analysis of K562 cells by confocal
microscopy confirmed the localization of the endogenous ABCB6
protein in the lysosomal compartment (labeled by LAMP1), and its
absence in mitochondria (labeled by CoxIV) (Figure 2A). Further
analysis of HeLa cells consistently showed that the endogenous
ABCB6 protein colocalizes primarily with lysosomal markers, and
is not expressed in the plasma membrane or mitochondria; HEK
cells expressing endogenous ABCB6 gave identical results (Figure
S1). To investigate whether the reported mitochondrial localiza-
tion of ABCB6 may be explained by an artefact linked to
overexpression systems used in those studies [14,16,17,21], we
transfected HeLa cells with a construct encoding a Flag-tagged
ABCB6 variant. This experimental approach also resulted in an
endolysosomal expression pattern that was clearly distinct from the
mitochondrial expression of ABCB7, ABCB8 or ABCB10
(Figure 2B and Table S1). Interestingly, at very high expression
levels, ABCB6 was also found in the plasma membrane, whereas
under the same experimental conditions the canonical mitochon-
drial ABC transporters remained confined to the mitochondria
(Figure S2).
ABCB6 is Expressed as a Full Length Glycoprotein in RBCs
ABCB6 is highly expressed in fetal liver, and ABCB6 protein
levels were reported to increase coordinately with globin levels
during the induced differentiation of proerythroblast cell lines
[14]. To expand the scope of our analysis from cancer cell lines
to models of higher physiological relevance, we analyzed
terminally differentiated red blood cells. As shown in Figure 3A,
Western blot analysis indicates that ABCB6 is expressed in
mature erythrocytes; imnunofluorescence analysis of fresh human
blood using two different anti-ABCB6 antibodies confirmed this
result (Figure S3). Following treatment of erythrocyte ghosts with
peptide N-glycosidase F (PNGaseF), a clear shift of the apparent
molecular weight is observed, indicating that ABCB6 is expressed
as an N-glycosylated protein in the plasma membrane of mature
erythrocytes (Figure 3B). According to the conventional wisdom,
mature red blood cells lack intracellular organelles. In fact, red
blood cells are completely devoid of mitochondria, since
mitochondria are removed in the final stages of erythroid
differentiation [31]. Thus, the presence of a glycosylated ABCB6
in mature erythrocytes is inconsistent with the presumed
mitochondrial localization of this protein in erythrocyte precur-
sors.
ABCB6 Is Dispensable for Erythropoiesis
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As erythrocytes differentiate from reticulocytes, we assessed the
presence and fate of ABCB6 in immature red blood cells. Mice
were phlebotomized to increase their reticulocyte count in blood
(up to 20%). Consistently, an increase in transferrin receptor (TfR)
expression was displayed by circulating red blood cells without
noticeable change in spectrin content (Figure S4A). Interestingly,
RBCs from anemic mice presented much higher amounts of
ABCB6 compared to those of healthy animals, suggesting a loss of
the ABC transporter during reticulocyte maturation into erythro-
cyte. Such loss of specific proteins during reticulocyte maturation
has been shown to occur through their association with exosomes.
Exosomes correspond to intralumenal vesicles of internal com-
partments called multivesicular endosomes (MVE), secreted in the
extracellular medium upon fusion of MVE with the plasma
membrane [32]. Thus, reticulocytes from mice treated with
phenylhydrazine were differentiated in vitro for 48 h and the
secreted exosomes were collected from the maturation medium.
The TfR and proteins classically taken as exosomal markers (Alix,
Tsg101, flotillin) were found in the released vesicles. Remarkably,
ABCB6 was also detected in the secreted exosomes and
consistently the amount of cell-associated transporter decreased
during in vitro maturation period, as in the case of the TfR (Figure
S4B). Conversely, B-spectrin, which is not lost during reticulocyte
maturation was not detected in exosomes [33]. Moreover, the
absence of porin in the exosomal fraction rules out a contamina-
tion by mitochondria exocytosed during reticulocyte differentia-
tion [31]. Accordingly, after reticulocyte fractionation, ABCB6
was recovered in plasma membrane, endosome and exosome
subfractions (not shown).
Human RBCs from reticulocyte-enriched blood was similarly
used for in vitro maturation (Figure 4A). Correspondingly, the
vesicles containing the exosomal markers (and not spectrin) were
enriched with TfR and ABCB6. Note that the exosomal
enrichment of the two cargo proteins is especially noticeable due
to the low reticulocyte count of human RBCs, accentuating the
final TfR and ABCB6 concentration in exosomal membrane
compared to RBCs plasma membrane. To confirm ABCB6
association with the vesicles, exosomes collected after reticulocyte
maturation were fractionated by flotation on sucrose gradient and
analyzed for the presence of TfR, Tsg101 and ABCB6 by Western
blot (Figure S5). TfR and Tsg101 were mainly detected in
fractions 5 to 8, corresponding to densities between 1.11 and
1.20 g/mL, in agreement with exosome characteristics [34].
Outstandingly, ABCB6 was distributed in the same fractions,
attesting its exosome association. Immunofluorescence study was
carried out on human RBCs and confirmed the higher expression
of ABCB6 on TfR-positive reticulocytes (Figure 4B).
ABCB6 is Coregulated with the Hemoglobin Content of
Induced K562 Cells, but is Dispensable for the Erythroid
Differentiation of K562 Cells
K562 cells can be differentiated along the erythroid lineage by a
variety of chemical compounds including hemin, and various
antitumor agents [29]. We investigated differentiating K562 cells
treated with the targeted Bcr-Abl tyrosine kinase inhibitor,
Gleevec (imanitib mesylate) [35] or hemin. Since imatinib is toxic
to K562 cells, experiments were conducted at conditions that
result in maximal hemoglobin production without inducing
apoptosis. At 72 hours after the induction with 150 nM imatinib
or 50 mM hemin, parental K562 cells contained elevated
quantities of hemoglobin as evidenced by the visible change in
the color of the cellular pellets (Figure S6) and an increase of
benzidine staining (Figure 5A). At 72 hours post induction,
ABCB6 protein levels were significantly increased – confirming
that ABCB6 expression is upregulated during erythroid matura-
tion and increased hemoglobin production [14].
It was hypothesized that the elevated expression of ABCB6
would promote mitochondrial porphyrin uptake and activate de
novo porphyrin biosynthesis, which can be readily followed
experimentally by measuring the protoporphyrin IX (PPIX)
fluorescence of the cells [14]. To verify this proposition, we
studied the effect of ABCB6 overexpression or shRNA-mediated
downregulation on the baseline PPIX-levels of stably transfected
K562 cells. Despite the high-yield overexpression of the wild type
ABCB6 protein or the effective downregulation of the endogenous
ABCB6 levels by inducible expression of short hairpin RNAs,
baseline PPIX-fluorescence of the different K562 cell lines cells did
not change significantly (Figure 5B). Finally, we characterized the
effect of ABCB6 silencing on the de novo heme synthesis of
induced K562 cells. Downregulation of ABCB6 protein levels did
not change the ability of Gleevec or hemin to enhance hemoglobin
production (Figure 5C), suggesting that ABCB6 is dispensable for
the induced de novo heme biosynthesis required for the chemically
induced erythroid differentiation of K562 cells.
Discussion
Of the ,1500 proteins identified in the erythrocytes, proteomic
studies have confirmed the presence of several ABC transporters,
Figure 1. ABCB6 is not present in the purified mitochondrial fraction of K562 cells. Cellular membranes were separated by differential
centrifugation (A); mitochondria were isolated using anti-TOM22 magnetic beads (B) as described in Materials and Methods. Following separation by
SDS-PAGE, organelle membranes were transferred to a PVDF membrane, which was incubated in antibodies recognizing specific organelle markers
and ABCB6. A. Cellular fractions corresponding to total cell lysate (lane 1); nuclei and intact cells (lane 2); mitochondrial pellet of the 80006g
centrifugation (lane 3); pellet of 12.0006g centrifugation (lane 4); pellet of 20.0006g centrifugation (lane 5). B. Isolation of mitochondria using TOM22
immunobeads. Total cell lysate (lane 1); fraction bound to the beads after repeated washing steps (lane 2); pellet of the flow through (lane 3).
doi:10.1371/journal.pone.0037378.g001
ABCB6 Is Dispensable for Erythropoiesis
PLoS ONE | www.plosone.org 3 May 2012 | Volume 7 | Issue 5 | e37378ABCB6 Is Dispensable for Erythropoiesis
PLoS ONE | www.plosone.org 4 May 2012 | Volume 7 | Issue 5 | e37378suggesting that the mature erythrocyte membrane is a major
repository of ABC proteins [36]. Here we show that ABCB6, a
protein currently assigned to mitochondria in the major protein
databases [37], is abundantly expressed in the erythrocyte
membrane. Our findings expand red blood cell proteomic data
that include ABCB6 fragments [38–40]. We show that ABCB6 is
expressed in its full length, glycosylated form, suggesting that the
plasma membrane localization in red blood cell does not rely on
erythrocyte-specific posttranslational modifications. The presence
of ABCB6 in red blood cells may seem logical in view of the
increased expression of ABCB6 in erythroid differentiation models
(Figure 5A and [14]). However, since mature erythrocytes do not
contain intracellular membrane compartments, plasma membrane
localization of ABCB6 is inconsistent with the presumed
mitochondrial localization of this protein in erythrocyte precur-
sors. Intracellular organelles such as mitochondria and endosomes
are lost during the final stage of differentiation through autophagy
and secretion [41]. In fact, the red blood cell ghosts are negative
for mitochondrial markers such as porin (Figure 3). We show that
ABCB6 is at least partly evacuated through exosome secretion.
Since exosomal cargo proteins must originate from the plasma
membrane-endosomal continuum, this result provides further
arguments against the presumed mitochondrial localization of
ABCB6. By filtering components to be secreted vs. components to
be recycled to the plasma membrane, exosome biogenesis also
contributes to RBC plasma membrane remodeling. Similarly to
the lysosomal protein LAMP2 [42], ABCB6 could be partly
redistributed to the plasma membrane of mature erythrocytes
during reticulocyte maturation by fusion of lysosomes with the
plasma membrane [43]. The functional relevance of such
‘‘neolocalized’’ cell surface proteins in RBCs awaits further
investigation.
At present, it is uncertain whether erythrocytic ABCB6 is
actually a bioactive molecule or a vestigial heritage from an
erythroid precursor. Similarly to ABCB7 and ABCB10, expression
of ABCB6 was shown to increase upon DMSO-induced differen-
tiation of mouse erythroleukemia (MEL) cells [44], suggesting that
these proteins may all share an important role in the regulation of
the heme synthetic pathway. While our data do not exclude the
possibility that ABCB6 may play a role in heme metabolism under
certain conditions that remain to be defined, the results presented
in this paper suggest that it does not mediate direct mitochondrial
uptake of porphyrins.
First, our morphological data show that ABCB6 is not identified
in purified mitochondria. Second, we show that the endogenous
and cDNA-derived human ABCB6 (NM_005689) is targeted to
the endolysosomal compartment, unlike ABCB7, ABCB8 or
ABCB10, which were found in the mitochondria. Third, ABCB6
is glycosylated, and to date only one mammalian glycoprotein has
been described in mitochondria, although this number could be
underestimated [45]. Finally, we show that differential expression
of ABCB6 does not influence baseline or induced porphyrin levels
in K562 cells.
It is well known that overexpression takes a toll on the
processing of proteins; tags may also derail intracellular targeting.
Whereas most localization data in the literature are based on the
Figure 2. Determination of the subcellular localization of ABCB6 by double immunofluorescence labeling and laser-scanning
confocal microscopy. A. Expression of the endogenous ABCB6 protein in K562 cells was visualized by the monoclonal ABCB6-567 antibody (green),
lysosomes and mitochondria were labeled with LAMP1 (red, lower panel) and CoxIV antibodies (red, upper panel), respectively. ABCB6 colocalizes
with LAMP1 (yellow on the overlay, r=0.79), but not with CoxIV (r=0.14). B. Flag-tagged ABC proteins were expressed following transient
transfection of HeLa cells. The cDNA-derived ABC transporters were visualized with an anti-FLAG tag antibody (green, left panel); mitochondria were
labeled with CoxIV (red, middle panel). Whereas the canonical mitochondrial ABC transporters are confined to the mitochondria (merged image, right
panel, r=0.87, r=0.7, r=0.84 for ABCB7, ABCB8 and ABCB10, respectively), ABCB6 does not show colocalisation with the mitochondrial marker
(merged image, right panel, r=0.13).
doi:10.1371/journal.pone.0037378.g002
Figure 3. ABCB6 is expressed as a full length glycoprotein in mature erythrocytes. A. Red blood cell ghosts (60 ug total protein, lane 1)
were solubilized and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE). After transfer to a PVDF membrane,
Western blot analysis was performed using a panel of custom-made and commercially available anti-ABCB6 antibodies as well as anti-porin to exlude
contamination by mitochondria. Membranes of K562 cells engineered to overexpress HA-tagged ABCB6 were loaded as a control (10 mg total protein,
lane 2). B. Red blood cell ghosts and ABCB6 overexpressing K562 cell lysates were treated with PNGase F enzyme to remove N-glycans. 20 ug total
protein was analyzed by SDS-PAGE, ABCB6 was visualized by the ABCB6-567 antibody.
doi:10.1371/journal.pone.0037378.g003
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PLoS ONE | www.plosone.org 5 May 2012 | Volume 7 | Issue 5 | e37378Figure 4. Human reticulocytes release ABCB6 in association with exosomes. A. 250 mL packed cells volume (PCV) of human RBCs from
reticulocyte-enriched (4.5%) blood was cultured for 48 h and exosomes were collected from the medium as previously described in [42]. 0.5 mL PCV
of RBCs before (t0) or after (48 h) maturation, as well as the completeness of exosomes were loaded on 10% SDS-PAGE for immunoblot analysis of
the indicated proteins. The molecular mass (kDa) standards are indicated on the left. Note that the TfR is not detected in RBCs due to the low
reticulocyte count but revealed in exosomes due to its concentration in the vesicles. B. Human RBCs from reticulocyte-enriched (10%) blood were
adsorbed on cover slips pretreated with poly-L-lysine, fixed 20 min by 1% PFA and immunostained for ABCB6 (antibody Ab 7474 at; dilution 1/:50/
Alexa Fluor 594; A21207) or and TfR (MoAb H68.4 at; dilution 1/:200/Alexa Fluor 488; A11029) after permeabilization, as described in the Materials and
Methods. Coverslips were observed using a Leica confocal SPE and a Leica 636 ACS APO 1.33 objective. Note that none of the cells shown are
positive to DAPI although contained in the mounting reagent. Arrows point to possible colocalization of ABCB6 and TfR in MVE.
doi:10.1371/journal.pone.0037378.g004
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PLoS ONE | www.plosone.org 6 May 2012 | Volume 7 | Issue 5 | e37378Figure 5. Porphyrin synthesis and ABCB6 expression in K562 cells. A. ABCB6 protein expression is upregulated in parental K562 cells upon
chemically induced erythroid differentiation. K562 cells were cultured for 72 h with 150 nM Gleevec or 50 mM hemin, the number of viable cells was
determined by trypan-blue staining. Hemoglobin levels were quantified by benzidine staining. Error bars represent SD of at least 5 experiments.
ABCB6 expression is revealed by the ABCB6-567 monoclonal antibody (60 ug total protein, 72 hours post-induction). Actin is shown as loading
control. B. Baseline PPIX-fluorescence of K562 cells is not influenced by ABCB6 levels. PPIX fluorescence was measured by flow cytometry as
explained in the Methods section, ABCB6 expression of the cells was revealed by the anti human ABCB6-567 monoclonal antibody (actin is shown as
loading control). Error bars represent SD of at least 3 experiments. Parental K562 cells (lane 1); K562 cells stably transfected with a non-target control
shRNA (lane 2) or ABCB6 shRNA construct (lane 3); K562 cells stably overexpressing wild-type ABCB6 (lane 4) or a non-functional mutant variant of
ABCB6 (ABCB6KM, lane 5). C. Downregulation of ABCB6 does not impede induced heme synthesis of K562 cells. K562 cells stably transfected with an
shRNA construct targeting ABCB6 or a scrambled control were cultured for 72 h with 150 nM imatinib or 50 mM hemin, hemoglobin levels were
quantified by benzidine staining. Error bars represent SD of at least 5 experiments.
doi:10.1371/journal.pone.0037378.g005
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we characterized the intracellular distribution of the endogenous
protein, in three human cell lines of different origin, using
complementary methods. We used a panel of custom-made and
commercially available antibodies. The specificity of the antibod-
ies was confirmed by immunoblotting and confocal microscopy
studies of cell lines expressing tagged variants of ABCB6 (Figure
S2, [17]). The major advantage of using antibodies to visualize the
subcellular localization of proteins is that genetic constructs are not
needed and that the possible artifactual effects of protein fusions
are avoided. However, while fusion proteins may enable
monitoring of dynamic changes, antibodies detect only a snapshot
of the dynamic process of protein distribution. Immuncytochem-
ical labeling of the ABCB6 protein with the currently available
antibodies requires fixed and permeabilized cells, limiting the
study to dynamically fixed end points. Under these conditions, the
distribution of the native ABCB6 primarily shows colocalisation
with lysosomes, and less so with the Golgi/ER markers (Table S2),
presumably because of the short half-life of ABCB6 in the latter
organelles (glycosylation proves that ABCB6 transits through the
ER-Golgi system [15,17]). Conversely, lack of mitochondrial
localization, especially in the context of the observed expression
pattern of ABCB7, ABCB8 and ABCB10 in the same experimen-
tal system indicates that ABCB6 does not reside in mitochondria.
K562 is a Philadelphia-positive erythroleukemia cell line that
has been widely used to study induced hemoglobin production,
even if this model does not fully recapitulate the complex
physiology of terminal erythropoiesis [29]. In K562 cells, targeted
inhibition of the oncogenic kinase initiates the entire differentia-
tion program leading to enhanced de novo heme biosynthesis and
ultimately to increased cellular hemoglobin levels [35]. In our
hands, treatment with hemin or the Bcr-Abl kinase inhibitor
Gleevec induced hemoglobin production and differentiation of
K562 cells toward the erythroid lineage, which was accompanied
by a significant increase of ABCB6 protein levels. However,
overproduction or downregulation of ABCB6 did not result in a
shift of baseline PPIX levels, and stable silencing by inducible
shRNA did not prevent differentiation-induced hemoglobin
upregulation of K562 cells. Notably, in a similar experimental
setup, silencing of ABCB10 interfered with the ability of K562
cells to undergo induced differentiation [46].
Careful analysis of the literature provides additional support to
our conclusions. A recent publication suggests that ABCB6 can be
silenced without a consequent decrease of cellular PPIX levels
[47]. Interestingly, abcb6-KO mice are viable and appear to be
hematologically normal, suggesting that ABCB6 is dispensable (Jill
Paterson, Gergely Szakacs, Michael M. Gottesman, unpublished
data). While this manuscript was in preparation, ABCB6 was
identified as the genetic basis of the Lan blood group antigen
expressed on red blood cells. Of note, Lan(-) (ABCB6(2/2))
individuals do not suffer any clinical consequences, suggesting that
ABCB6 is dispensable for erythropoiesis in humans [48].
Heterologous expression of rat Abcb6 in a human adenocarcino-
ma cell line resulted in a subcellular localization confined to the
endo/lysosomal compartment [21]. ABCB6 was also found to be
expressed in the plasma membrane [17]. While we don’t see
evidence of the plasma membrane expression of ABCB6 in the cell
lines analyzed in this study, we note that at high expression levels,
cDNA-derived ABCB6 appears in the plasma membrane of HeLa
cells. The continuum of the endolysosomal and plasma membrane
compartments, as well as the abundance of ABCB6 in red cells
adds further relevance of this finding. Data assembled by recent
proteomic efforts contain reference to lysosomal localization [20].
Lysosomes are organelles of eukaryotic cells that are critically
involved in the degradation of macromolecules mainly delivered
by endocytosis and autophagy. The lysosomal membrane facili-
tates interaction and fusion with other compartments and harbors
transport proteins catalyzing the export of catabolites, thereby
allowing their recycling [49]. Given the ATP-dependence of ABC
transporters, the ATP-binding domain of ABCB6 is expected to
face the cytoplasm, predicting ABCB6 to be a lysosomal importer.
In addition to Atm1p, ABCB6 is also homologous to the heavy
metal tolerance factor 1 (HMT1) of Caenorhabditis elegans and
Schizosaccharomyces pombe. HMT1 is a half transporter that confers
tolerance to heavy metal toxicity in Schizosaccharomyces pombe [50]
and tolerance to cadmium in Caenorhabditis elegans [51]. Notably,
HMT1 is a vacuolar protein, which protects cells against metal
toxicity by promoting the sequestration of metal adducts into the
vacuolar interior. Interestingly, a possible role of ABCB6 in metal
tolerance has been suggested in the literature. Direct correlation
between arsenic resistance and ABCB6 expression was observed in
various human and mouse cell lines [17,52]. Knockdown of
ABCB6 expression sensitized HepG2 and Hep3B cells to arsenite
toxicity, and stable overexpression of ABCB6 conferred a strong
survival advantage towards arsenite-induced oxidative stress [53].
These results are consistent with the prediction that ABCB6, as a
functional orthologue of HMT1, pumps transition metal com-
plexes into the interior of acidic vesicles.
Further work is needed to elucidate the functional relevance of
ABCB6 in the pathophysiology of erythroid cells. It is possible that
ABCB6 offers protection of the erythrocyte by excreting heme
degradation products. In addition to the erythrocytic membrane,
the snapshots of our morphological studies locate ABCB6 in the
endo-lysosomal compartment of cells. This compartment includes
different membrane organelles that interact together through
specific targeting mechanisms and fusion processes in order to
degrade, sort and recycle material of different origin. Interestingly,
ABCB6 and TfR are expressed in the same endosomal compart-
ment in HeLa cells (not shown), which is consistent with a
colocalisation in an intracellular compartment of the erythroid
precursors such as the multivesicular endosome, bringing about
exosome production. In the complex dynamics of a living cell,
endosomes may transiently contact mitochondria as part of the
organelle-mediated delivery of iron observed in reticulocytes
[54,55,56]. Could this transient interaction account for the
reported mitochondrial localization and presumed function of
ABCB6 in cell lines? The findings presented in this paper do not
support this notion. While we do not exclude the contribution of
ABCB6 to porphyrin metabolism, our results clearly show that
ABCB6 is unlikely to be directly responsible for the mitochondrial
uptake of porphyrins. We also show that ABCB6 function is not
required for de novo heme biosynthesis in differentiating K562
cells, excluding this ABC transporter as a key regulator of
porphyrin synthesis. At the same time we confirm the mitochon-
drial localization of ABCB7, ABCB8 and ABCB10, suggesting that
only three ABC transporters should be classified as mitochondrial
proteins. Taken together, our results challenge the current
paradigm linking the expression and function of ABCB6 to
mitochondria. The identification of the subcellular localization of
ABCB6 should pave the way for studies aimed at the elucidation of
its true physiological function.
Materials and Methods
Ethics Statement
Animal protocols were reviewed and approved by the Institu-
tional Animal Care and Use Committee of the University
Montpellier II. Reticulocyte-enriched blood (always .4%) was
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anemia, during routine follow-up visits to the ‘‘Ho ˆpital St Eloi’’
(Montpellier, France), as approved by the Montpellier University
Hospital’s ethics committee. Control blood was obtained from
healthy volunteers, as approved by the Montpellier University
Hospital’s ethics committee. All subjects gave their written
informed consent to participate in the study, which was approved
by the Montpellier University Hospital’s ethics committee.
DNA Constructs
cDNA encoding wild-type human ABCB6 (NM_005689)
bearing an HA-tag at its C-terminus [17] was mutated by
mutagenic PCR to generate a variant harboring mutation of a
universally conserved lysine residue in the Walker A sequence
(K629M). The HA-tagged ABCB6 and the non-functional
ABCB6-variant (ABCB6HA and ABCB6HA-KM, respectively)
were cloned into pBabe retroviral vectors (AddGene plasmid
1764). An untagged form of both the wild-type and the non-
functional mutant variant of ABCB6 (K629M, ABCB6-KM) were
cloned into pSEW lentiviral vectors. The pLKO.1-puro36LacO
inducible shRNA vectors targeting human ABCB6 or expressing a
nonsense hairpin were purchased from Sigma. For transient
transfection, a C-terminally Flag-tagged ABCB6 construct was
created by PCR mutagenesis and subcloning into a 36FLAG-
CMV-14 vector (Sigma-Aldrich). pCMV-ABCB7, pCMV-ABCB8
and pCMV-ABCB10, containing C-terminally Flag-tagged con-
structs were kind gifts from Jill Paterson.
Cell Lines, Culture Conditions
The K562 cell line (American Type Culture Collection) was
kindly provided by Bela Papp, Inserm, Paris. Cells were grown in
RPMI medium without nucleosides, supplemented with 10% (v/v)
fetal bovine serum (Invitrogen Cat.No. 10106-169) and with 2 mM
glutamine, 100 units/mL penicillin, and 100 mg/mL streptomycin
(Invitrogen-Gibco, Carlsbad, CA, USA) at 37uC in humidified air/
CO2 (19:1) atmosphere. ABCB6-HA and its non-functional KM
mutant variant (ABCB6-HA KM) were expressed in K562 cells
using retroviral transduction. Briefly, the Phoenix-eco packaging
cell line was transfected by using the ExGene transfection system
(Fermentas). The cell-free viral supernatant was collected at 48
hours after transfection, and was immediately used to transduce
PG13 cells. The Phoenix-eco cell line [57] was a gift from G. Nolan
(Department ofPharmacology, Stanford University, Stanford, CA);
PG13 retrovirus producing cells were obtained from ATCC
(Manassas, VA). For the generation of ABCB6 knock-down cell
lines, lentiviral particles were produced by following the manufac-
turer’s instructions. To induce the expression of the shRNA
constructs, IPTG (1 mM) was added to the cells for 48 hours before
additional treatments. Untagged variants of ABCB6 were stably
expressed in K562 cells by lentiviral transduction as described
above,andtransiently expressedinHeLacells(Sigma)followingthe
instructions of the FuGENE HD Transfection kit (Promega). Since
we found that Mycoplasma infection significantly influences the
baseline fluorescence of cells (thus interfering with measurements of
protoporphyrin IX (PPIX) levels), cell lines were regularly screened
with the Mycoplasm Detection Kit (Lonza), and the assays were
carried out in mycoplasma-negative cells.
Antibodies
The following primary antibodies were used in Western blotting
experiments: ß-actin (A1978, Sigma-Aldrich); ABCB6-567,
ABCB6-788 and ABCB6-7474 [17], ABCB6 (Sc98685, Santa
Cruz); porin (A31855, Invitrogen); LAMP1 (611043, BD Biosci-
ences); NaK-ATPase (BML-SA247-0100, Biomarker); CoxIV
(A21348, Invitrogen); Lac-I (AP09404PU-S, Acris antibodies,
Germany); BXP21; TfR (H68.4, Invitrogen); Flotillin-1 (610820,
BD Biosciences); Tsg 101 (4A10, Abcam); Alix (R. Sadoul,
INSERM U836, Grenoble) and B-spectrin (N. Mohandas, NY
Blood Center). HRP-conjugated secondary antibodies were
purchased from Jackson Immuno Research Laboratories. The
following primary antibodies were used for confocal microscopy:
anti-Flag (F3165, Sigma); panCadherin (Ab16505, Abcam);
giantin (Ab24586, Abcam); Lamp1 (L1418, Sigma); LAMP1
(611043, BD Bioscience); calnexin and CoxIV (Cellular Localiza-
tion IF Antibody Sampler Kit, Cell Signaling, #4753). Fluores-
cently labeled secondary antibodies (goat anti-mouse IgGs
conjugated with Alexa Fluor 647 A21235, Alexa Fluor 594
A11005 or Alexa Fluor 488 A10667; goat anti-rabbit IgGs
conjugated with Alexa Fluor 647 A21244, Alexa Fluor 594
A11012 or Alexa Fluor 488 A11008) were purchased from
Invitrogen.
Differentiation of K562 Cells, Measurement of Baseline
PPIX Fluorescence
K562 cells (2610
5/mL) were treated with various drugs for 3
days. Cells were grown beyond the logarithmic growth phase (i.e.
over 10
6cells/mL); diluted to 2610
5 cells/mL and treated with
Gleevec immediately. For hemin treatments, the inducer was
added to the diluted cultures after a four hour-long lag period;
hemin was solubilised as described [58]. Special attention was
given not to disturb air/CO2 (19:1) atmosphere throughout the
differentiation process. Viability was determined by trypan blue
exclusion. Hemoglobin content of K562 cells was determined by
the benzidine technique of Luftig [59] et al. with minor
modifications: cells were lysed in a lysis buffer (50 mM Tris
pH=7,4; 250 mM NaCl; 2% Nonidet-P 40) at a density of
5610
7/ml. The hemoglobin content of clear supernatants was
determined as described previously [60]. PPIX fluorescence was
measured using an Attune acoustic focusing cytometer (Applied
Biosystems, Life Technologies Corp. USA) equipped with a
405 nm (violet) laser and a 640 nm longpass filter.
Confocal Microscopy
K562 cells were gently washed with Dulbecco’s modified
phosphate-buffered saline (DPBS), fixed with 4% paraformalde-
hyde (PFA) in DPBS for 10 minutes at room temperature, dried on
histopathological slides in drops, washed with DPBS, and
permeabilized in methanol for 90 seconds at room temperature.
The samples were blocked for 1 h at room temperature in DPBS
containing 2 mg/mL BSA, 1% fish gelatin, 0.1% Triton-X 100
and 5% goat serum. The cells were then incubated for 1 h at room
temperature with the primary antibody diluted in blocking buffer.
After washing with DPBS, the cells were incubated for 1 hour at
room temperature with the respective Alexa Fluor-conjugated
secondary antibody diluted at 1:250 in blocking buffer. Where
indicated, DAPI was diluted in DPBS and added to the cells after
the incubation with the secondary antibody, for 10 minutes at
room temperature. Wheat Germ Agglutinin was added to living
cells before the immunostaining procedure and incubated for
10 min at 37uC. To label cellular organelles, the following dyes
were used: MitoTracker Red CMXos fixable dye (Invitrogen,
M7512), LysoTracker Red DND-99 (Invitrogen, L7528), DAPI
(49,6-diamidino-2-phenylindole, dihydrochloride, D1306) and
Alexa Fluor 633 conjugate of WGA (W21404). Samples were
studied with an Olympus IX-81/FV500 laser scanning confocal
microscope, using an Olympus PLAPO 606 (1.4 NA) oil
immersion objective (Olympus Europa GmbH). Dual channel
colocalization analysis was performed by the ImageJ software with
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Dual channel colocalization analysis was performed by the ImageJ
software with the Colocalization Threshold and Colocalization
Test plugins. Averaged Manders’ and Pearson’s coefficients are
reported for each subcellular marker from 5 random pictures
manders [61–62].
Isolation of Erythrocytes and Reticulocytes
Human blood was freshly drawn into heparin from healthy
volunteers. Cells were spun at 10000 rpm at 4uC for 10 min. The
plasma and the buffy coat were removed by suction, and the red
blood cells were washed three times with PBS. Reticulocyte-
enriched blood (always .4%) was obtained from patients with
pathological states, such as hemolytic anemia, during routine
follow-up visits to the ‘‘Ho ˆpital St Eloi’’ (Montpellier, France), as
approved by the relevant institutional review boards. After
centrifugation, the plasma and the buffy coat were removed, and
the red blood cells were washed twice with Ringer solution.
Anemia was induced in swiss-OF1 mice via two injections of an
aqueous solution of phenylhydrazine hydrochloride (PHZ) (6 mg/
mL) at the dose 60 mg/kg of on days 1 and 2. Mice were then
sacrificed on day 6 by cardiac puncture under anaesthesia.
Alternatively, reticulocytosis was induced by phlebotomy. Blood
(0.5 ml) was removed from retroorbital vein on days 0 and 2. On
day 4, animals were sacrificed and blood was collected by cardiac
puncture. After removing the buffy coat, red blood cells were
washed twice with Ringer solution, and used for fractionation or in
vitro maturation. For control experiments, erythrocytes were
obtained from the blood of untreated mice.
Isolation of Organelle Membranes
Cellular fractions were isolated by differential centrifugation.
Cells were washed with ice cold PBS and were resuspended in
buffer A [10 mM NaCl, 1.5 mM MgCl2, 10 mM Tris (pH 7.4)]
containing protease inhibitors (8 mg/mL aprotinine, 10 mg/mL
leupeptine, 50 mg/mL PMSF) and 2 mM DTT, swollen on ice,
and disrupted with a Dounce homogenizer (150 strokes). Buffer B
[525 mM mannitol, 175 mM sucrose, 12.5 mM Tris (pH 7.4),
and 2.5 mM EDTA] was added in a ratio of 4:10 homogenate/
buffer B (cell lysate: Figure 1A, lane 1). The nuclei and unbroken
cells were removed by a low speed centrifugation (13006g) for
10 min at 4uC as described in [63] (Figure 1A, lane 2). This step
was repeated until no pellet was visible. The clear supernatant was
centrifuged at medium speed (80006g, 20 min) to get a fraction
enriched in mitochondria (Figure 1A, lane 3) and the supernatant
was further centrifuged at 120006g for 30 min. The resulting
pellet was free of mitochondria (Figure 1A, lane 4). The
supernatant was further centrifuged at 200006g for 45 min
(Figure 1A, lane 5). The pellet of each separation step was
dissolved in Laemmli buffer (0,05 M Tris-PO4 (pH: 6.8), 2% SDS,
2% B-merchaptoethanol, 0,002 M EDTA (pH 6.8), 20% glycerol,
0,02% bromphenol blue in ultra pure water) and sonicated for
12 sec. Equal amounts (protein) were subjected to SDS PAGE
analysis.
Mitochondria were isolated using Miltenyi’s Mitochondria
Isolation Kit (cat.no: 130-094-532), with minor modifications of
the protocol to increase the purity of the mitochondria. Briefly,
2610
7 cells were washed with ice cold PBS and resuspended in
1 mL Lysis Buffer supplemented with 8 mg/ml aprotinine, 10 mg/
mL leupeptine and 50 mg/mL PMSF (Sigma). Cells were broken
in a Dounce homogenizer (150 strokes) and a 29G needle (10
strokes) (Figure 1B, lane 1). Nuclei and unbroken cells were
removed with a low speed centrifugation step (5 min, 2506g, 4uC).
800 mL cell lysate was mixed with 6.3 mL of Separation Buffer
and 30 mL anti-TOM22 MicroBeads was added to label
mitochondria. The mixture was incubated for 60 min at 4uCi n
a tube rotator. The labeled cell lysate was transferred into a
4.5 mL polystyrene tube, which was placed into a magnetic
separator column (EasySep, StemCell Technologies) for 10
minutes at 4uC. Following magnetic separation the supernatant
was removed and the beads were washed with isolation buffer
(3 mL). After 3 cycles of separation and washing, the solution
containing labeled mitochondria was centrifuged at 120006g
10 min, 4uC, the pellet was resuspended in Laemmli buffer
(Figure 1B, lane 2). The supernatants from the washing steps were
pooled and centrifuged at 100006g for 10 min; the resulting
supernatant was centrifuged at 180006g for 30 min at 4uC, the
pellet was subjected to SDS PAGE (Figure 1B, lane 3).
Reticulocyte Subcellular Fractionation
Mouse red blood cells were lysed by freezing/thawing as
described previously [64]. The lysed cells were pelleted at 15006g
for 5 min and the supernatant was centrifuged (30 000 rpm for
15 min in a Beckman TLA110 rotor) to pellet mitochondria and
cell debris. An ultracentrifugation (70000 rpm for 2 h in a
Beckman TLA110 rotor) finally allowed separating endosomes
(pellet) from cytosol (supernatant). Endosomes were resuspended
in PBS. Erythrocyte and reticulocyte plasma membranes were
prepared according to Steck and Kant [65] with red blood cells
from healthy and anemic mice, respectively. Animal protocols
were reviewed and approved by the Institutional Animal Care and
Use Committee of the University Montpellier II.
Exosome Isolation
Red blood cells were cultured for 48 h at 37uC in RPMI 1640
supplemented with 5 mM glutamine, 5 mM adenosine, 10 mM
inosine, 3% FCS, depleted for endogenous exosomes by overnight
ultracentrifugation (100 0006g), 50 U/ml penicillin and 50 mg/
ml streptomycin. After pelleting the cells, the culture supernatant
was centrifuged (20 0006g for 20 min) to remove cellular debris.
Exosomes were separated from the supernatant by ultracentrifu-
gation (100 0006g for 2 h) and resuspended in sucrose 250 mM,
Hepes 5 mM pH 7.4 or directly in Laemmli buffer, depending on
the experiments. Exosomes collected from the 48 h maturation
medium of human reticulocyte-enriched red blood cells (RBCs)
were layered on top of a linear sucrose gradient (0.5–2.5 M
sucrose) in a Beckman SW55 tube. Gradients were centrifuged at
equilibrium for 16 h at 39 000 rpm, after which 350 mL fractions
were collected from the top of the tube. Fraction densities were
determined by refractometry. Proteins in collected fractions were
precipitated by TCA, and samples were separated by SDS-PAGE
using 10% polyacrylamide gels and the proteins were electropho-
retically transferred to PVDF membrane (Immobilon-P; Millipore,
Bedford, MA). Membranes were blocked for 1 hour in TBST
(10 mM Tris–HCl, pH 8.0, 150 mM NaCl, 0.05% Tween 20)
containing 5% skim milk, followed by 1 h incubation with the
indicated primary antibodies. Blots were washed and incubated for
1 h at room temperature with the secondary antibody (horserad-
ish-peroxidase (HRP)-conjugated). Immunoreactive bands were
visualized by the enhanced chemiluminescence method (ECL,
Amersham Bioscience) according to standard procedures. The
membranes were stripped by overnight incubation with 0.2 M
glycine, 0.1% SDS, 1% Tween 20, pH 2.2 and re-probed after
washing with TBST and blocking with 5% skim milk.
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Figure S1 Determination of the subcellular localization
of endogenous ABCB6 by double immunofluorescence
labeling and laser-scanning confocal microscopy. A.
HeLa cells probed by the ABCB6-567 antibody to detect the
endogenous ABCB6 protein (green) in the context of intracellular
markers (red): CoxIV (mitochondria), panCadherin (plasma
membrane), giantin (Golgi), calnexin (ER) and LysoTracker
(lysosomes). ABCB6 colocalizes essentially with the lysosomal
marker. B. HEK cells probed by the ABCB6-567 antibody to
detect the endogenous ABCB6 protein (green) in the context of
intracellular markers (red): WGA (plasma membrane), CoxIV
(mitochondria) and Lamp1 (lysosomes). ABCB6 colocalizes
essentially with the lysosomal marker.
(TIF)
Figure S2 Flag-tagged ABCB6 expressed in HeLa cells.
Following transient transfection of HeLa cells with Flag-tagged
ABCB6, cells were probed with anti-tag and ABCB6-567
antibodies. Proteins recognized by the antitag antibody are also
labeled with ABCB6-567, suggesting that the monoconal antibody
ABCB6-567 specifically recognizes ABCB6. Note that at very high
expression levels, ABCB6 can also be found in the plasma
membrane in addition to its main intracellular localization (bottom
panel).
(TIF)
Figure S3 Imnunofluorescence analysis of fresh human
blood using two different anti-ABCB6 antibodies: 74740
(A) and Santa Cruz (B), both revealed with an Alexa 594-
coupled secondary antibody. A control with the secondary
only is shown (C). DIC: differential interference contrast. Fresh
human RBC (,48 h after sampling) group O+ were obtained
from the French Blood center. The cells were washed with PBS
and fixed in PBS with 4% of paraformaldehyde (EMS sciences) 4
hours at room temperature (RT). Cells were washed, treated with
0.1 M glycine in PBS for 15 minutes at (RT), and then
permeabilized with 0.1% Triton X-100 in PBS for 10 minutes at
RT. The cells were washed once and resuspended in 3% fetal calf
serum (FCS). Antibodies were diluted in Washing Solution (PBS
1% FCS). The cells were incubated with the primary antibodies
for 1 h at RT. After 3 washes, the cells were incubated with the
secondary antibodies (anti-rabbit alexa 594, Molecular Probes) for
1 h and washed 3 times. A thin film was made on a glass slide and
mounted with a coverslip and one drop of vectashield (Vector).
Observations were made using a Zeiss Axioimager equipped with
an apotome, with a 636 apochromat objective and Differential
interference contrast. Luminosity and contrasts were adjusted
using the Axiovision software.
(TIF)
Figure S4 ABCB6 expression and fate during reticulo-
cyte maturation. A. Proteins from 0.5 mL packed cell volume
(PCV) of RBCs from healthy or phlebotomized mice were
separated on 10% SDS-PAGE, transferred on PVDF membrane
and analyzed by Western blot for the presence of the indicated
proteins after membrane staining/destaining using Coomassie
blue. The molecular mass (kDa) standards are indicated on the
right. B. 200 mL PCV of RBCs from PHZ-treated mouse was
cultured for 48 h and exosomes were collected from the medium
as described in the Materials and Methods. 0.5 mL PCV of RBCs
before (t0) or after (48 h) maturation, and the completeness of
exosomes were loaded on 10% SDS-PAGE for immunoblot
analysis of the indicated proteins. Note that the 55 kDa band
detected by the anti-ABCB6 (567) in RBCs and exosomes was
frequently found (4/8 mice) in PHZ-treated mice and could
correspond to a degradation product or to a shorter form reported
by Paterson et al [17]. It has to be noted that additional bands may
represent nonspecific reactions between the antibody generated
against human ABCB6 and various murine proteins.
(TIF)
Figure S5 Sucrose gradient analysis of hRBC exosomes.
Exosomes were obtained after in vitro maturation (48 h) of hRBCs
(4% reticulocytes) by differential centrifugation, and layered on top
of a linear sucrose gradient (0.5–2.5 M sucrose) in a Beckman
SW55 tube. Gradients were centrifuged at equilibrium for 16 h at
39 000 rpm, after which 350 mL fractions were collected from the
top of the tube. Fractions were collected and analyzed by Western
blot for the indicated proteins. Densities (g/mL) were obtained for
each fraction by refractometry and are indicated under each lane.
Note that a significant amount of protein was detected on top of
the gel by the anti-ABCB6 (657), which indicates that part of the
transporter could form aggregates during TCA precipitation.
(TIF)
Figure S6 Pelleted K562 cells. 72 hours after the induction
with 150 nM imatinib or 50 mM hemin, K562 cells contained
elevated quantities of hemoglobin as evidenced by the visible
change in the color of the cellular pellets.
(TIF)
Table S1 Statistics of colocalization analysis between
the mitochondrial marker CoxIV, ABCB6 and the
mitochondrial ABC proteins. Flag-tagged ABC proteins were
expressed following transient transfection of Hela cells. The
cDNA-derived ABC transporters were visualized with an anti-
FLAG tag antibody, mitochondria were labeled with CoxIV. Dual
channel colocalization analysis was performed by the ImageJ
software with the Colocalization Threshold and Colocalization
Test plugins. Averaged Pearson’s coefficients were calculated for
each subcellular marker from 5 random pictures.
(DOC)
Table S2 Colocalization of endogenous ABCB6 and
different subcellular markers in HeLa cells. LysoTracker
was used as lysosomal, pancadherin as plasma membrane,
calnexin as ER, giantin as Golgi and CoxIV as mitochondrial
marker, as described in Methods section.
(DOC)
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